Histone lactylation pathway in hair cycle: deacylases and their protein targets
毛发周期中的组蛋白乳酰化途径:脱酰酶及其蛋白质靶标
基本信息
- 批准号:10623277
- 负责人:
- 金额:$ 67.68万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-07-01 至 2026-04-30
- 项目状态:未结题
- 来源:
- 关键词:AcetylationAcetyltransferaseAreaBehaviorBiochemicalBiochemistryBioinformaticsBiologyCell physiologyCellsChIP-seqChemicalsChemistryChromatinCoenzyme ACultured CellsDNADataData SetDeacetylaseDiabetes MellitusDiseaseEP300 geneEnergy MetabolismEnvironmentEnzymatic BiochemistryEnzymesEpigenetic ProcessFoundationsGene Expression RegulationGenesGoalsGrowthHairHair follicle structureHistone DeacetylaseHistonesHumanHypoxiaImmune responseInfrastructureKnock-outKnowledgeLaboratoriesLysineMalignant NeoplasmsMass Spectrum AnalysisMediatingMetabolismMethylationModificationMolecularMusPathologicPathway interactionsPeriodicityPhasePhysiologicalPhysiologyPlayPositioning AttributePost-Translational Protein ProcessingProteinsProteomicsReactionRegulatory ElementRegulatory PathwayResearchResting PhaseRoleSiteSkinSubstrate SpecificitySystemTestingTissuesTranscriptional RegulationWarburg EffectWestern Blottingadult stem cellchromatin immunoprecipitationdeep sequencingepigenetic regulationexperimental studyinsightknock-downoverexpressionprogramsresponsestem cell differentiationstem cellstranscriptome sequencing
项目摘要
Emerging lines of evidence suggest an intimate crosstalk among energy metabolism, metabolites and
epigenetics. Post-translational modifications (PTMs) on histones (histone “marks”) (e.g., lysine acetylation
(Kac) and methylation (Kme)) are known to be regulated by metabolism, contributing to the epigenetic
programs that are associated with cellular physiology and disease. However, we do not yet know if additional
histone PTM pathways exist and if they can be modulated by diverse cellular metabolites. Thus, chemistry and
biochemistry of metabolites-mediated chromatin changes remain poorly characterized. Lactate, a widely known
cellular metabolite, can be dramatically induced under some cellular conditions (e.g. hypoxia) and in the
Warburg effect, an observation most commonly shared among diverse cancers and associated with many
diseases. Lactate concentration can rise to 20-40 mM in cancer tissues. Although this compound was
discovered ~200 years ago, its non-metabolic functions in physiology (e.g., hypoxia, stem cell differentiation
and immunoresponse) and disease (e.g., cancer and diabetes) remain unknown, representing a long-standing
question in biology. We recently discovered a lactate-derived, new lysine modification, lysine lactylation (Kla).
We comprehensively validated this PTM by chemical and biochemical approaches. This PTM can be
stimulated by the Warburg effect-derived lactate and has different temporal dynamics from the widely studied
lysine acetylation (Kac). Our epigenetic studies suggest that histone Kla represents a new type of metabolism-
regulated epigenetic changes and contributes to gene regulation. We hypothesize that the histone Kla pathway
is molecularly distinct from Kac pathway and contribute to gene regulation. We therefore propose to
characterize the Kla pathway by defining its key regulatory elements: enzymes that can remove the
modification (or delactylases), and their targets on histones and non-histone substrate proteins. We will also
study their role in epigenetic regulation in cyclic behavior of hair follicle stem cells (HFSCs) in which lactate and
its regulatory enzyme play a key role. We will use an integrated strategy involving chemical biology,
enzymology, quantitative proteomics, and biochemistry approaches. The knowledge gained from this study will
likely have a broad impact on our understanding of epigenetics, and will lay a foundation for studying Kla and
the Warburg effect.
新出现的证据表明能量代谢、代谢物和代谢物之间存在密切的串扰。
组蛋白的表观遗传学(PTM)(组蛋白“标记”)(例如赖氨酸乙酰化)
(Kac)和甲基化(Kme))已知受代谢调节,有助于表观遗传
与细胞生理学和疾病相关的计划但是,我们还不知道是否还有其他计划。
组蛋白 PTM 途径存在,并且它们是否可以通过多种细胞代谢物进行调节。
代谢物介导的染色质变化的生物化学仍然知之甚少,乳酸是一种广为人知的物质。
细胞代谢物,在某些细胞条件下(例如缺氧)和在
瓦尔堡效应,一种在多种癌症中最常见的观察结果,并与许多癌症相关
尽管这种化合物在癌症组织中可能会升高至 20-40 mM。
约 200 年前发现,其生理学中的非代谢功能(例如缺氧、干细胞分化)
和免疫反应)和疾病(例如癌症和糖尿病)仍然未知,代表着长期存在的一个问题
我们最近发现了一种源自乳酸的新赖氨酸修饰,即赖氨酸乳酰化 (Kla)。
我们通过化学和生化方法全面验证了该 PTM。
受到瓦尔堡效应衍生的乳酸的刺激,并且具有与广泛研究的不同的时间动态
我们的表观遗传学研究表明,组蛋白 Kla 代表了一种新型代谢 -
我们研究组蛋白 Kla 通路调控表观遗传变化并有助于基因调控。
在分子上与 Kac 途径不同,并且有助于基因调控。
通过定义其关键调控元件来表征 Kla 途径:可以去除 Kla 途径的酶
我们还将讨论修饰(或脱乳酰酶)及其对组蛋白和非组蛋白底物蛋白的作用。
研究它们在毛囊干细胞 (HFSC) 循环行为的表观遗传调控中的作用,其中乳酸和
它的调节酶发挥关键作用,我们将采用涉及化学生物学的综合策略,
从这项研究中获得的知识将包括酶学、定量蛋白质组学和生物化学方法。
可能会对我们对表观遗传学的理解产生广泛的影响,并将为研究 Kla 和
瓦尔堡效应。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
The Acyl-CoA Specificity of Human Lysine Acetyltransferase KAT2A.
- DOI:10.1021/acs.biochem.2c00308
- 发表时间:2022-09-06
- 期刊:
- 影响因子:2.9
- 作者:Anmangandla, Ananya;Ren, Yuxiang;Fu, Qin;Zhang, Sheng;Lin, Hening
- 通讯作者:Lin, Hening
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Hening Lin其他文献
Hening Lin的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Hening Lin', 18)}}的其他基金
Design and development of HDAC11-specific chemical inhibitors for disease treatments
用于疾病治疗的 HDAC11 特异性化学抑制剂的设计和开发
- 批准号:
10360661 - 财政年份:2021
- 资助金额:
$ 67.68万 - 项目类别:
Histone lactylation pathway in hair cycle: deacylases and their protein targets
毛发周期中的组蛋白乳酰化途径:脱酰酶及其蛋白质靶标
- 批准号:
10412929 - 财政年份:2021
- 资助金额:
$ 67.68万 - 项目类别:
Design and development of HDAC11-specific chemical inhibitors for disease treatments
用于疾病治疗的 HDAC11 特异性化学抑制剂的设计和开发
- 批准号:
10205726 - 财政年份:2021
- 资助金额:
$ 67.68万 - 项目类别:
Design and development of HDAC11-specific chemical inhibitors for disease treatments
用于疾病治疗的 HDAC11 特异性化学抑制剂的设计和开发
- 批准号:
10581571 - 财政年份:2021
- 资助金额:
$ 67.68万 - 项目类别:
Metabolite Sensing and Regulation of Protein Function
蛋白质功能的代谢传感和调节
- 批准号:
10613940 - 财政年份:2019
- 资助金额:
$ 67.68万 - 项目类别:
Metabolite Sensing and Regulation of Protein Function
蛋白质功能的代谢传感和调节
- 批准号:
9912164 - 财政年份:2019
- 资助金额:
$ 67.68万 - 项目类别:
Metabolite Sensing and Regulation of Protein Function
蛋白质功能的代谢传感和调节
- 批准号:
10395458 - 财政年份:2019
- 资助金额:
$ 67.68万 - 项目类别:
Screening and Development of Small Molecule HDAC11 Inhibitors to Treat Obesity and Diabetes.
治疗肥胖和糖尿病的小分子 HDAC11 抑制剂的筛选和开发。
- 批准号:
10319956 - 财政年份:2019
- 资助金额:
$ 67.68万 - 项目类别:
SIRT6 and lysine fatty acylation in macrophage inflammation
SIRT6 和赖氨酸脂肪酰化在巨噬细胞炎症中的作用
- 批准号:
9210624 - 财政年份:2016
- 资助金额:
$ 67.68万 - 项目类别:
SIRT6 and lysine fatty acylation in macrophage inflammation
SIRT6 和赖氨酸脂肪酰化在巨噬细胞炎症中的作用
- 批准号:
9009646 - 财政年份:2016
- 资助金额:
$ 67.68万 - 项目类别:
相似国自然基金
FHF1招募乙酰转移酶p300调控复极储备在心肌肥厚室性心律失常中的作用及机制
- 批准号:82360072
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
组蛋白乙酰转移酶GCN5调控糖脂代谢促进胶质母细胞瘤干细胞活力的机制与功能研究
- 批准号:82373095
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
SCML4协同乙酰化转移酶HBO1促进Trm表观遗传修饰增强抗肿瘤免疫的分子机制研究
- 批准号:82303153
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
EB病毒v-snoRNA1结合乙酰转移酶NAT10上调鼻咽癌HLA-E表达促进NK细胞耗竭的机制研究
- 批准号:82303069
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
家蚕组蛋白乙酰转移酶BmMOF与BmNPV晚期表达因子LEF-6互作抑制病毒侵染的分子机制研究
- 批准号:32302818
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Combined bromodomain and CDK4/6 inhibition in NUT Carcinoma and other solid tumors
溴结构域和 CDK4/6 联合抑制 NUT 癌和其他实体瘤
- 批准号:
10577265 - 财政年份:2023
- 资助金额:
$ 67.68万 - 项目类别:
Epigenetic mechanisms of histone methyltransferase ASH1L in autism spectrum disorder
组蛋白甲基转移酶 ASH1L 在自闭症谱系障碍中的表观遗传机制
- 批准号:
10743048 - 财政年份:2023
- 资助金额:
$ 67.68万 - 项目类别:
In vivo tracing of hepatic ethanol metabolism to histone acetylation: role of ACSS2 in alcohol-induced liver injury
肝脏乙醇代谢与组蛋白乙酰化的体内追踪:ACSS2 在酒精性肝损伤中的作用
- 批准号:
10667952 - 财政年份:2023
- 资助金额:
$ 67.68万 - 项目类别:
Lysine Acetylation and the Regulation of Vasopressin/Aquaporin System in the Principal Cell
主细胞中赖氨酸乙酰化和加压素/水通道蛋白系统的调节
- 批准号:
10445263 - 财政年份:2021
- 资助金额:
$ 67.68万 - 项目类别:
Defining the role of short-chain fatty acids in adolescent opioid reinforcement and epigenetic regulation
定义短链脂肪酸在青少年阿片类药物强化和表观遗传调控中的作用
- 批准号:
10576350 - 财政年份:2021
- 资助金额:
$ 67.68万 - 项目类别: